Capital Markets Trading (UK)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$211K Sell
176
-562
-76% -$574K ﹤0.01% 347
2026
Q1
$679K Buy
738
+549
+290% +$557K 0.01% 251
2025
Q4
$203K Sell
189
-397
-68% -$380K ﹤0.01% 295
2025
Q3
$447K Buy
+586
New +$436K 0.01% 268

Other funds holding LLY

Capital Markets Trading (UK)'s LLY Position: Q2 2026 in Review

Capital Markets Trading (UK) reduced its Eli Lilly (LLY) stake by 76% in Q2 2026, selling an estimated $574K and leaving 176 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #347.

Capital Markets Trading (UK) first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. The position peaked at $679K in Q1 2026. 4,639 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Capital Markets Trading (UK) held 176 shares of Eli Lilly worth $211K as of Q2 2026.
  • Capital Markets Trading (UK) sold 562 Eli Lilly shares in Q2 2026, an estimated $574K.
  • Eli Lilly made up ﹤0.01% of Capital Markets Trading (UK)'s portfolio in Q2 2026, its #347 holding.
  • Capital Markets Trading (UK) first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • Capital Markets Trading (UK)'s Eli Lilly position peaked at $679K in Q1 2026.
  • 4,639 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capital Markets Trading (UK)'s 13F filing for Q2 2026, filed 13 Aug 2026.